{"transactions":[{"id":777518,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:14:01.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":5351,"source":{"system":"sec-edgar","filing":"0001730038-26-000004","document":"wk-form4_1778876036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000173003826000004/wk-form4_1778876036.xml","form_type":"4"}},{"id":893378,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2026-02-19T22:00:19.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":395066,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares subject to the option award shall vest on February 17, 2027, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Ordinary Shares may be represented by American Depositary Shares.  Each American Depositary Share represents one Ordinary Share."}],"balance_after":395066,"derivative":{"exercise_price":32.38,"expiration_date":"2036-02-16","underlying":"Ordinary Shares","underlying_shares":395066},"source":{"system":"sec-edgar","filing":"0001730038-26-000002","document":"form4-02192026_050209.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000173003826000002/form4-02192026_050209.xml","form_type":"4"}},{"id":893377,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Share Units","published_at":"2026-02-19T22:00:19.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":88573,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one Ordinary Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest in four equal annual installments beginning February 17, 2027, subject to the Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vest in four equal annual installments beginning February 17, 2027, subject to the Reporting Person's continuous service through each such vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Ordinary Shares may be represented by American Depositary Shares.  Each American Depositary Share represents one Ordinary Share."}],"balance_after":88573,"derivative":{"underlying":"Ordinary Shares","underlying_shares":88573},"source":{"system":"sec-edgar","filing":"0001730038-26-000002","document":"form4-02192026_050209.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000173003826000002/form4-02192026_050209.xml","form_type":"4"}},{"id":893376,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Share Units","published_at":"2026-02-19T22:00:19.000Z","date":"2026-02-17","kind":"exercise","planned":false,"acquired":false,"shares":23817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one Ordinary Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On February 17, 2025, the Reporting Person was granted 95,270 RSUs, vesting in four equal annual installments beginning February 17, 2026, subject to the Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On February 17, 2025, the Reporting Person was granted 95,270 RSUs, vesting in four equal annual installments beginning February 17, 2026, subject to the Reporting Person's continuous service through each such vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Ordinary Shares may be represented by American Depositary Shares.  Each American Depositary Share represents one Ordinary Share."}],"balance_after":71453,"derivative":{"underlying":"Ordinary Shares","underlying_shares":23817},"source":{"system":"sec-edgar","filing":"0001730038-26-000002","document":"form4-02192026_050209.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000173003826000002/form4-02192026_050209.xml","form_type":"4"}},{"id":893375,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-02-19T22:00:19.000Z","date":"2026-02-18","kind":"sale","planned":false,"acquired":false,"shares":11474,"price":32.35,"value":371183.9,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Ordinary Shares may be represented by American Depositary Shares.  Each American Depositary Share represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares were sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted share units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.17 to $32.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":12343,"source":{"system":"sec-edgar","filing":"0001730038-26-000002","document":"form4-02192026_050209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000173003826000002/form4-02192026_050209.xml","form_type":"4"}},{"id":893374,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-02-19T22:00:19.000Z","date":"2026-02-17","kind":"exercise","planned":false,"acquired":true,"shares":23817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Ordinary Shares may be represented by American Depositary Shares.  Each American Depositary Share represents one Ordinary Share."}],"balance_after":23817,"source":{"system":"sec-edgar","filing":"0001730038-26-000002","document":"form4-02192026_050209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000173003826000002/form4-02192026_050209.xml","form_type":"4"}},{"id":1145887,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-16T20:17:12.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":4788,"source":{"system":"sec-edgar","filing":"0001156039-25-000088","document":"wk-form4_1747426626.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000088/wk-form4_1747426626.xml","form_type":"4"}},{"id":1259960,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Share Units","published_at":"2025-02-19T21:17:09.000Z","date":"2025-02-17","kind":"grant","planned":false,"acquired":true,"shares":95270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit (\"RSU\") represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in four equal annual installments beginning February 17, 2026, subject to the Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in four equal annual installments beginning February 17, 2026, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":95270,"derivative":{"underlying":"Ordinary Shares","underlying_shares":95270},"source":{"system":"sec-edgar","filing":"0001415889-25-004602","document":"form4-02192025_090204.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588925004602/form4-02192025_090204.xml","form_type":"4"}},{"id":1259959,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2025-02-19T21:17:09.000Z","date":"2025-02-17","kind":"grant","planned":false,"acquired":true,"shares":405824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option award shall vest on February 17, 2026, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":405824,"derivative":{"exercise_price":29.6,"expiration_date":"2035-02-16","underlying":"Ordinary Shares","underlying_shares":405824},"source":{"system":"sec-edgar","filing":"0001415889-25-004602","document":"form4-02192025_090204.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588925004602/form4-02192025_090204.xml","form_type":"4"}},{"id":1512053,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-17T20:23:12.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":4187,"source":{"system":"sec-edgar","filing":"0001156039-24-000084","document":"wk-form4_1715977369.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000084/wk-form4_1715977369.xml","form_type":"4"}},{"id":1629285,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2024-02-21T21:15:29.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":281819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option award shall vest on February 16, 2025, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":281819,"derivative":{"exercise_price":70.5,"expiration_date":"2034-02-15","underlying":"Ordinary Shares","underlying_shares":281819},"source":{"system":"sec-edgar","filing":"0001415889-24-004590","document":"form4-02212024_040209.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588924004590/form4-02212024_040209.xml","form_type":"4"}},{"id":1667888,"issuer":{"id":4699,"kind":"organization","name":"ArriVent BioPharma, Inc."},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-29T21:15:57.000Z","date":"2024-01-25","kind":"grant","planned":false,"acquired":true,"shares":17884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest on the first anniversary of the grant date, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":17884,"derivative":{"exercise_price":18,"expiration_date":"2034-01-24","underlying":"Common Stock","underlying_shares":17884},"source":{"system":"sec-edgar","filing":"0001104659-24-007732","document":"tm244377-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730038/000110465924007732/tm244377-1_4seq1.xml","form_type":"4"}},{"id":1895361,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-12T20:21:58.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":3799,"source":{"system":"sec-edgar","filing":"0001156039-23-000072","document":"wf-form4_168392290042931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603923000072/wf-form4_168392290042931.xml","form_type":"4"}},{"id":2226718,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RESTRICTED STOCK UNITS","published_at":"2022-06-17T22:03:09.000Z","date":"2022-06-15","kind":"exercise","acquired":false,"shares":1814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Stock Units vest in full on the one-year anniversary of the grant date, June 15th, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable for Restricted Stock Units."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"COMMON STOCK","underlying_shares":1814},"source":{"system":"sec-edgar","filing":"0001576280-22-000046","document":"wf-form4_165550336542100.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576280/000157628022000046/wf-form4_165550336542100.xml","form_type":"4"}},{"id":2226717,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2022-06-17T22:03:09.000Z","date":"2022-06-15","kind":"exercise","acquired":true,"shares":1814,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7408,"source":{"system":"sec-edgar","filing":"0001576280-22-000046","document":"wf-form4_165550336542100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576280/000157628022000046/wf-form4_165550336542100.xml","form_type":"4"}},{"id":2262237,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-20T20:48:05.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Phantom Stock units accrued under the Anthem, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":3342,"source":{"system":"sec-edgar","filing":"0001156039-22-000062","document":"wf-form4_165307967082290.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000062/wf-form4_165307967082290.xml","form_type":"4"}},{"id":2660123,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RESTRICTED STOCK UNITS","published_at":"2021-06-21T21:26:29.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":1814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in full on the one-year anniversary of the grant date, June 16th, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable for Restricted Stock Units."}],"balance_after":1814,"derivative":{"exercise_price":0,"underlying":"COMMON STOCK","underlying_shares":1814},"source":{"system":"sec-edgar","filing":"0001576280-21-000071","document":"wf-form4_162431075861171.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576280/000157628021000071/wf-form4_162431075861171.xml","form_type":"4"}},{"id":2660122,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2021-06-21T21:26:29.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":3135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the one-year anniversary of the grant date, June 16th, 2022."}],"balance_after":3135,"derivative":{"exercise_price":117.19,"expiration_date":"2031-06-15","underlying":"COMMON STOCK","underlying_shares":3135},"source":{"system":"sec-edgar","filing":"0001576280-21-000071","document":"wf-form4_162431075861171.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576280/000157628021000071/wf-form4_162431075861171.xml","form_type":"4"}},{"id":2691645,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T20:30:46.000Z","date":"2021-05-26","kind":"grant","acquired":true,"shares":493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Phantom Stock units accrued under the Anthem, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":2902,"source":{"system":"sec-edgar","filing":"0001156039-21-000060","document":"wf-form4_162223381300697.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000060/wf-form4_162223381300697.xml","form_type":"4"}},{"id":3108389,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2020-06-16T21:55:46.000Z","date":"2020-06-12","kind":"grant","acquired":true,"shares":4840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the earlier to occur of (i) June 12, 2021 and (ii) the date of the next annual meeting of the Issuer's stockholders."}],"balance_after":4840,"derivative":{"exercise_price":77.09,"expiration_date":"2030-06-11","underlying":"COMMON STOCK","underlying_shares":4840},"source":{"system":"sec-edgar","filing":"0001628280-20-009562","document":"wf-form4_159234452903713.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576280/000162828020009562/wf-form4_159234452903713.xml","form_type":"4"}},{"id":3108388,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2020-06-16T21:55:46.000Z","date":"2020-06-12","kind":"grant","acquired":true,"shares":2757,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5594,"source":{"system":"sec-edgar","filing":"0001628280-20-009562","document":"wf-form4_159234452903713.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576280/000162828020009562/wf-form4_159234452903713.xml","form_type":"4"}},{"id":3135451,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-26T20:34:35.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":699,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Phantom Stock units accrued under the Anthem, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":2409,"source":{"system":"sec-edgar","filing":"0001156039-20-000046","document":"wf-form4_159052525807174.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000046/wf-form4_159052525807174.xml","form_type":"4"}},{"id":3521446,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-05-17T20:15:54.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Phantom Stock units accrued under the Anthem, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless\na later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":1710,"source":{"system":"sec-edgar","filing":"0001127602-19-018989","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760219018989/form4.xml","form_type":"4"}},{"id":3551995,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2019-04-19T22:40:41.000Z","date":"2019-04-17","kind":"grant","acquired":true,"shares":4526,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in equal annual installments over 3 years commencing on April 17, 2019."}],"balance_after":4526,"derivative":{"exercise_price":72.71,"expiration_date":"2029-04-16","underlying":"COMMON STOCK","underlying_shares":4526},"source":{"system":"sec-edgar","filing":"0001628280-19-004540","document":"wf-form4_155571362598381.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730038/000162828019004540/wf-form4_155571362598381.xml","form_type":"4"}},{"id":3551994,"issuer":{"id":3238,"kind":"organization","name":"Guardant Health, Inc.","symbol":"GH"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2019-04-19T22:40:41.000Z","date":"2019-04-17","kind":"grant","acquired":true,"shares":2837,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2837,"source":{"system":"sec-edgar","filing":"0001628280-19-004540","document":"wf-form4_155571362598381.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730038/000162828019004540/wf-form4_155571362598381.xml","form_type":"4"}},{"id":3926054,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-05-18T20:23:02.000Z","date":"2018-05-16","kind":"grant","acquired":true,"shares":753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Phantom Stock units accrued under the Anthem, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless\na later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":957,"source":{"system":"sec-edgar","filing":"0001127602-18-018136","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218018136/form4.xml","form_type":"4"}},{"id":4076643,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-02-05T21:41:22.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Phantom Stock units accrued under the Anthem, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless\na later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":204,"source":{"system":"sec-edgar","filing":"0001127602-18-004013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218004013/form4.xml","form_type":"4"}}]}